19LDA FILINGS
8LOBBYISTS
0FLY-INS
Federal Lobbying Spend
$970K
Total LDA-disclosed spend (in-house + retained) across all reported periods.
Most recent LDA filing posted April 2026.
Topics in Filings
52Policy topics named in LD-2 filings. This org's filings are topical rather than positional — these are the issues it's actively lobbying on, even without a stated verb of position.
Prescription Drug Pricing Policy×12
Maintaining Investments in New Innovation Act×8
Medicare and Medicaid Issues×8
ORPHAN Cures Act×8
340B Program×4
Alzheimer's Disease×4
Diagnostics for patients with rare disease×4
Drug pricing×4
Education around innovative testing for early detection of lung cancer and draft×4
Financial Services and General Government Appropriations Act×4
FY 2026×4
General education about Calyxo×4
Show all 52 topics (+40 more) ▾
General Education on Apollo Global Management×4
General education on Compass Pharmaceuticals×4
General education on kidney care×4
General education on the School Reform×4
General higher education issues×4
General issues×4
HELP Copays Act×4
Hepatitis C Funding×4
Home Infusion for Part B Products×4
Insurance regulation×4
Lab test regulatory and reimbursement reform×4
Labor-HHS Appropriations Bill×4
Labor/workforce filing×4
Lung Cancer Screening and Prevention Act×4
Medicaid drug rebate program×4
Medicare Contractor Reform×4
Medicare coverage of molecular testing for solid organ allograft rejection×4
Medicare payment of clinical laboratory tests×4
Medicare Physician Fee Schedule Provider Reimbursement×4
Medicare reimbursement for diagnostics×4
Medicare Reimbursement for New Technologies×4
Medicare Reimbursement for Prescription Drugs×4
Medicare/Medicaid payment reform×4
Mental health and PTSD×4
Multi-Cancer Early Detection×4
Oncology/Artificial Intelligence×4
PAMA AUC×4
Pediatric Priority Review Voucher Program×4
PET scan coverage and reimbursement and dementia care. 340B Program×4
PPRV×4
Prescription drug pricing×4
Prescription drug pricing, including MDRP×4
Prior authorization of molecular tests×4
Prostate cancer screening×4
Screening and Diagnosis×4
Student Loan issues×4
Substance Use Disorder Policy×4
Supply Chain Issues×4
Value of imaging×4
Women's health×4
Bills in Play
5Bills referenced in this org's LD-2 filing text. Frequency = how many activities reference each.
Lobbyists on Record
8ERIC BERGRENformer Chief of Staff, Rep. Brett Guthrie; Staff Assis…
KATHERINE COTTONformer Staff Assistant, Legislative Correspondent, Leg…
PAUL EDATTELformer Chief Health Counsel, House Energy & Commerce C…
TED LEHMANformer Chief of Staff, Senator Tillis; Senate Judiciar…
NICOLAS MAGALLANESformer Senior Advisor - House Republican Conference; P…
PETER OPPENHEIMformer General Counsel, Senate HELP Committee; Asst. S…
DANIEL TODDformer Senior Health Counsel, Senate Finance Committee…
NICHOLAS UEHLECKEformer Senior Advisor, Dept. of Health and Human Servi…